TrialClinical cancer research : an official journal of the American Association for Cancer Research2024

A Phase II Study Assessing Long-term Response to Ibrutinib Monotherapy in Recurrent or Refractory CNS Lymphoma.

Christian Grommes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.